(a) For a patient with chronic nonmalignant pain, a prescriber, at a minimum and in addition to any additional requirements of the appropriate licensing board, shall:
(1) Check the prescriptive history of the patient on the Prescription Drug Monitoring Program at least every six (6) months; and
(2) Have a signed pain contract with the patient that states, at a minimum, the expectations of the prescriber for the behavior of the patient which may include:
(A) A requirement for random urine drug screenings to help ensure that the patient is abiding by the requirements of the contract; and
(B) A requirement for random pill counts to ensure compliance with the prescription.
(b) The requirements of this section shall not apply to a patient:
(1) Whose pain medications are being prescribed for a malignant condition;
(2) With a terminal condition;
(3) Who is a resident of a licensed healthcare facility;
(4) Who is enrolled in a hospice program; or
(5) Who is in an inpatient or outpatient palliative care program.
Section: Previous 20-7-702 20-7-703 20-7-704 20-7-705 20-7-706 20-7-707 20-7-708 NextLast modified: November 15, 2016